Atom Investors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,250
Closed -$3.43M 841
2025
Q4
$3.43M Buy
+17,250
New +$3.49M 0.27% 126
2024
Q3
Sell
-6,718
Closed -$894K 602
2024
Q2
$894K Sell
6,718
-11,255
-63% -$1.35M 0.09% 265
2024
Q1
$1.89M Sell
17,973
-7,031
-28% -$632K 0.24% 144
2023
Q4
$1.89M Buy
+25,004
New +$1.59M 0.33% 101
2023
Q3
Sell
-3,179
Closed -$259K 507
2023
Q2
$259K Buy
+3,179
New +$226K 0.1% 208
2021
Q4
Sell
-17,004
Closed -$1.13M 401
2021
Q3
$1.13M Sell
17,004
-11,551
-40% -$819K 0.09% 118
2021
Q2
$1.91M Buy
28,555
+10,438
+58% +$647K 0.24% 78
2021
Q1
$942K Buy
+18,117
New +$916K 0.16% 114

Other funds holding THC

Atom Investors's THC Position: Q1 2026 in Review

Atom Investors sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 17,250 shares — an estimated $3.43M sold.

Atom Investors first reported a position in THC in Q1 2021 and held it in 8 quarters. The position peaked at $3.43M in Q4 2025. 695 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Atom Investors reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 17,250 Tenet Healthcare shares in Q1 2026, an estimated $3.43M.
  • Atom Investors first reported a position in Tenet Healthcare in Q1 2021 and held it in 8 quarters.
  • Atom Investors's Tenet Healthcare position peaked at $3.43M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.